Exclusive: Virbac’s New CEO on Investment, Innovation & Long-Term Growth Strategy

0:00 Welcome to Animal Health Insider 1:07 First Exclusive: Paul Martingell, CEO of Virbac 2:07 200 Days In: First Impressions of Animal Health 5:31 One Health in Action: Why Animals Have Never Mattered More 6:54 What Makes Animal Health Different from Human Pharma 11:05 First acquisition as CEO 15:10 Area of Investment 18:13 Major Growth Drivers 21:15 The 2030 Profitability Target — and What Has to Go Right 23:01 Unlocking Underutilized Innovation 28:44 2026 Outlook: Growth, Market Share, and Performance 30:37 Breakthrough Innovation 33:54 Culture of Curiosity, Customer Obsession, and Performance 41:15 Becoming the Partner of Choice in Animal Health 45:30 A Surprising Thing not on the CV 50:25 Final Reflections and What’s Next for Virbac What does new leadership at a top 10 animal health company signal for the future of the industry? In this exclusive interview, Virbac’s new CEO Paul Martingell joins Animal Health Insider for his first in-depth industry conversation since stepping into the role. Paul shares his early impressions of animal health, what he learned from leading through transformation, and how those experiences are helping to guide Virbac’s next chapter. From R&D investment and long-term growth strategy to innovation, manufacturing, and culture, this conversation explores what it takes to compete and win in today’s evolving animal health landscape. We also discuss: 📈 Virbac’s growth ambitions and 2030 profitability targets 💰 Investing through uncertainty and why R&D matters now more than ever 🐾 Breakthrough innovation 🐄 Underutilized opportunities in livestock 🌍 Sustainability, One Health, and where the industry is headed next If you are watching leadership transitions closely, thinking about capital allocation, or evaluating where animal health innovation is going, this is one you will not want to miss. #AnimalHealth #Veterinary #Virbac #Biotech #leadershiptraining About Animal Health Insider Animal Health Insider takes you behind the scenes of the Animal Health industry. Each episode starts with conversation from the “Insiders,” followed by in-depth conversations with the leaders and disruptors shaping what’s next. If you work in #AnimalHealth, #Veterinary, #Biotech, #Agtech, #Sustainability, #Investment, or #PublicPolicy, subscribe for sharper context and real insight from the people on the inside of the industry. 🌐 Learn more at https://www.lawlesscomms.com/podcast/ LawlessComms Ready to build industry influence and engage employees through strategic communications made for Animal Health? We’re here to help. 🌐 https://www.lawlesscomms.com/ LinkedIn: https://www.linkedin.com/in/julielawless Stonehaven Transactions With decades of commercial and legal experience in M&A and other transactions in the animal health sector, Stonehaven Transactions guides small and large life science companies and investors through buy-side or sell-side transactions, license deals and commercial collaborations, ensuring value maximization, a seamless process, optimized synergies, and long-term growth. 🌐 https://sc.group/transactions/ LinkedIn: https://www.linkedin.com/in/dr-beatrice-vos-4184201 S&P Global Animal Health Beyond the headlines, S&P Global Animal Health provides expert insights for your animal health business. 🌐 https://www.spglobal.com/commodity-insights/en/industries/agriculture/animal-health LinkedIn: https://www.linkedin.com/in/joseph-harvey-08109916